NFE2L2 and prion disease: Interestingly, activation of the UPR has been utilized as a potential treatment against CJD [123], whereas p62 mediated Nrf2 activation and subsequent upregulation of autophagy levels has been proposed as a therapeutic strategy for prion diseases [6].